The European Commission announced on Saturday that all new electronic devices sold in the European Union (E.U.) must support ...

Nkarta focuses on autoimmune diseases, with $402.5M in cash. Read why NKTX stock, currently undervalued, offers multiple ...

In a groundbreaking development, researchers at KAIST (Korea Advanced Institute of Science and Technology) unveiled a new ...

Apple’s smartwatch has become synonymous with innovation and quality. With its extensive features and seamless integration ...

Showing a ray of hope, South Korean researchers have discovered a way that can potentially change cancerous cells back to normal.

What’s the outlook—and opportunity—for CX in 2025? It looks like 2025 will be another year of CX mediocrity for most brands. Don’t lose hope! For the bold CX leaders who are ready to kick things into ...

The most-read stories published by Multiple Sclerosis News Today in 2024 focused on living with MS and news on disease risk ...

This is a significant departure from traditional cancer treatments that rely on killing cancer cells, often leading to severe ...

Working with a line of colon cancer cells, Korean researchers figured out a way to throw a few genetic switches to cause the ...

Posadas, Mexico’s largest independent hotel operator, plans to expand to the Caribbean islands of Jamaica and Aruba. An ...

A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them, thus avoiding side ...

Chromatin is a combination of DNA and proteins that makes up the chromosomes in the cells of humans and other higher ...